Rituxan plus Temodar Effective for Primary Central Nervous System Lymphoma

Submitted by mike Tue 05/31/2005

Share on Tumblr

Call (877) 399-6937 or click here to learn more about Cancer Treatment options.

Researchers from Italy have reported that the combination of Rituxan (rituximab) and Temodar (temozolomide) is an effective treatment regimen for patients with primary central nervous system (CNS) non-Hodgkin’s lymphoma (NHL). This phase II study was presented at the 2005 meeting of the American Society of Clinical Oncology in Orlando, Florida, May 13-17 2005.

Primary central nervous system lymphoma is a relatively uncommon form of (NHL) that has been increasing in incidence over the past three decades. Unlike the progress made in general NHL treatment, there has been little progress in the treatment of CNS NHL. The standard treatment has been high-dose methotrexate and whole-brain radiotherapy. However, treatment-related neurotoxicity is common, especially in the elderly. Temodar is an alkylating agent used to treat primary and secondary brain tumors, especially glioblastoma multiforme.

More can be found in this article.

Call (877) 399-6937 or click here to learn more about Cancer Treatment options.

Support Groups

SupportGroups.com

For individuals, friends and families who are looking to connect during life's challenging times. Share personal experiences, evaluate information and get support during times of need, illness, treatment or recovery.

Cancer Support Groups

Find a Treatment Facility Near You

Click on a state below to find Lymphoma treatment options that could be right for you.

Select a State Below

The information provided on the Lymphoma Information Network is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her health professional. This information is solely for informational and educational purposes. The publication of this information does not constitute the practice of medicine, and this information does not replace the advice of your physician or other health care provider. Neither the owners or employees of LymphomaInfo.net nor the author(s) of site content take responsibility for any possible consequences from any treatment, procedure, exercise, dietary modification, action or application of medication which results from reading this site. Always speak with your primary health care provider before engaging in any form of self treatment. Please see our Legal Statement for further information.